Drula R, Pardini B, Fu X, Cruz De Los Santos M, Jurj A, Pang L
Proc Natl Acad Sci U S A. 2023; 120(23):e2122053120.
PMID: 37252969
PMC: 10266002.
DOI: 10.1073/pnas.2122053120.
Fahme P, Ramadan F, Le D, Nguyen Thi K, Ghayad S, Hussein N
Cancers (Basel). 2022; 14(24).
PMID: 36551531
PMC: 9776013.
DOI: 10.3390/cancers14246043.
Winkler J, Liu P, Phong K, Hinrichs J, Ataii N, Williams K
Proc Natl Acad Sci U S A. 2022; 119(11):e2115308119.
PMID: 35263230
PMC: 8931256.
DOI: 10.1073/pnas.2115308119.
Sinha P, Rani A, Kumar A, Riva A, Brant J, Foster T
Front Aging Neurosci. 2021; 13:717032.
PMID: 34421577
PMC: 8371553.
DOI: 10.3389/fnagi.2021.717032.
Bellanger A, Le D, Vendrell J, Wierinckx A, Pongor L, Solassol J
Front Oncol. 2021; 11:647269.
PMID: 34277402
PMC: 8283766.
DOI: 10.3389/fonc.2021.647269.
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications.
Zattarin E, Leporati R, Ligorio F, Lobefaro R, Vingiani A, Pruneri G
Cells. 2020; 9(12).
PMID: 33316954
PMC: 7764472.
DOI: 10.3390/cells9122644.
Bayesian Network Marker Selection via the Thresholded Graph Laplacian Gaussian Prior.
Cai Q, Kang J, Yu T
Bayesian Anal. 2020; 15(1):79-102.
PMID: 32802246
PMC: 7428197.
DOI: 10.1214/18-ba1142.
Epigenetic control of embryo-uterine crosstalk at peri-implantation.
Kong S, Zhou C, Bao H, Ni Z, Liu M, He B
Cell Mol Life Sci. 2019; 76(24):4813-4828.
PMID: 31352535
PMC: 11105790.
DOI: 10.1007/s00018-019-03245-8.
The potential influence of breast cancer estrogen receptors' distribution on active DNA demethylation.
Linowiecka K, Urbanowska-Domanska O, Guz J, Foksinski M
Contemp Oncol (Pozn). 2019; 23(2):74-80.
PMID: 31316288
PMC: 6630393.
DOI: 10.5114/wo.2019.85200.
A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients.
Pineda B, Diaz-Lagares A, Perez-Fidalgo J, Burgues O, Gonzalez-Barrallo I, Crujeiras A
Clin Epigenetics. 2019; 11(1):33.
PMID: 30786922
PMC: 6381754.
DOI: 10.1186/s13148-019-0626-0.
and Methylation Attenuates Tubulin Expression and Cell Stiffness in Cancer.
Chen C, He B, Chen Y, Lee K, Tung C, Hsu C
Int J Mol Sci. 2018; 19(10).
PMID: 30249017
PMC: 6212922.
DOI: 10.3390/ijms19102884.
Preliminary Study of the Role F-Box Protein 32 (FBXO32) in Colorectal Neoplasms Through the Transforming Growth Factor beta (TGF-β)/Smad4 Signalling Pathway.
Yuan X, Zhang Z, Jiang K, Wang X, Li Y
Med Sci Monit. 2018; 24:1080-1088.
PMID: 29465067
PMC: 5829536.
DOI: 10.12659/msm.908030.
A New Role for ERα: Silencing via DNA Methylation of Basal, Stem Cell, and EMT Genes.
Ariazi E, Taylor J, Black M, Nicolas E, Slifker M, Azzam D
Mol Cancer Res. 2017; 15(2):152-164.
PMID: 28108626
PMC: 5308451.
DOI: 10.1158/1541-7786.MCR-16-0283.
Beyond transcription factors: how oncogenic signalling reshapes the epigenetic landscape.
Liu F, Wang L, Perna F, Nimer S
Nat Rev Cancer. 2016; 16(6):359-72.
PMID: 27220480
PMC: 5548460.
DOI: 10.1038/nrc.2016.41.
Estradiol differentially induces progesterone receptor isoforms expression through alternative promoter regulation in a mouse embryonic hypothalamic cell line.
Vazquez-Martinez E, Camacho-Arroyo I, Zarain-Herzberg A, Rodriguez M, Mendoza-Garces L, Ostrosky-Wegman P
Endocrine. 2015; 52(3):618-31.
PMID: 26676302
DOI: 10.1007/s12020-015-0825-1.
Changes in DNA methylation are associated with the development of drug resistance in cervical cancer cells.
Chen C, Lee K, Pai M, Chu P, Hsu C, Chiu C
Cancer Cell Int. 2015; 15:98.
PMID: 26464562
PMC: 4604021.
DOI: 10.1186/s12935-015-0248-3.
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value.
Cohen P, Donini C, Nguyen N, Lincet H, Vendrell J
Oncotarget. 2015; 6(39):41566-81.
PMID: 26431164
PMC: 4747174.
DOI: 10.18632/oncotarget.5893.
Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells.
Yao-Borengasser A, Monzavi-Karbassi B, Hedges R, Rogers L, Kadlubar S, Kieber-Emmons T
Oncol Rep. 2015; 33(6):2689-94.
PMID: 25823469
PMC: 4431437.
DOI: 10.3892/or.2015.3880.
MicroRNA regulation of molecular pathways as a generic mechanism and as a core disease phenotype.
Ben-Hamo R, Efroni S
Oncotarget. 2015; 6(3):1594-604.
PMID: 25593195
PMC: 4359317.
DOI: 10.18632/oncotarget.2734.
The many faces of estrogen signaling.
Vrtacnik P, Ostanek B, Mencej-Bedrac S, Marc J
Biochem Med (Zagreb). 2014; 24(3):329-42.
PMID: 25351351
PMC: 4210253.
DOI: 10.11613/BM.2014.035.